Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
about
Striatal Gαolf/cAMP Signal-Dependent Mechanism to Generate Levodopa-Induced Dyskinesia in Parkinson's Disease.Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease.Striatal But Not Extrastriatal Dopamine Receptors Are Critical to Dopaminergic Motor Stimulation.Striatal synapses, circuits, and Parkinson's disease.
P2860
Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Dopaminergic treatment weakens ...... in the parkinsonian striatum.
@en
Dopaminergic treatment weakens ...... in the parkinsonian striatum.
@nl
type
label
Dopaminergic treatment weakens ...... in the parkinsonian striatum.
@en
Dopaminergic treatment weakens ...... in the parkinsonian striatum.
@nl
prefLabel
Dopaminergic treatment weakens ...... in the parkinsonian striatum.
@en
Dopaminergic treatment weakens ...... in the parkinsonian striatum.
@nl
P2093
P2860
P921
P356
P1476
Dopaminergic treatment weakens ...... in the parkinsonian striatum.
@en
P2093
Fu-Ming Zhou
Shengyuan Ding
P2860
P304
P356
10.1152/JN.00683.2016
P407
P577
2016-12-07T00:00:00Z